Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor

BACKGROUND AND OBJECTIVES: Obesity is a global epidemic which increases the risk of the metabolic syndrome. Cathelicidin (LL-37 and mCRAMP) is an antimicrobial peptide with an unknown role in obesity. We hypothesize that cathelicidin expression correlates with obesity and modulates fat mass and hepa...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Int J Obes (Lond)
Main Authors: Tran, Deanna Hoang-Yen, Tran, Diana Hoang-Ngoc, Mattai, S. Anjani, Sallam, Tamer, Ortiz, Christina, Lee, Elaine C., Robbins, Lori, Ho, Samantha, Lee, Jung Eun, Fisseha, Elizabeth, Shieh, Christine, Sideri, Aristea, Shih, David Q, Fleshner, Philip, McGovern, Dermot PB, Vu, Michelle, Hing, Tressia C., Bakirtzi, Kyriaki, Cheng, Michelle, Su, Bowei, Law, Ivy, Karagiannides, Iordanes, Targan, Stephan R., Gallo, Richard L., Li, Zhaoping, Koon, Hon Wai
פורמט: Artigo
שפה:Inglês
יצא לאור: 2016
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014693/
https://ncbi.nlm.nih.gov/pubmed/27163748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ijo.2016.90
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים